 |
|
|
| |
Resmetirom Improves the Lipid/Lipoprotein Profile in Patients With Nonalcoholic Fatty Liver Disease
|
| |
| |
EASL 2023 June 21-24 Vienna
Naim Alkhouri,1 Rebecca Taub,2 Guy W. Neff,3 K. Jean Lucas,4 Dominic Labriola,2 Sam E. Moussa,5 Mustafa R. Bashir,6 Stephen A. Harrison7
1Arizona Liver Health, Tucson, AZ, USA; 2Madrigal Pharmaceuticals, Conshohocken, PA, USA; 3Covenant Metabolic Specialists, Sarasota, FL, USA; 4Lucas Research, Morehead City, NC, USA; 5University of Arizona for Medical Sciences, Tucson, AZ, USA; 6Duke University Medical Center, Durham, NC, USA; 7University of Oxford, Oxford, United Kingdom and Pinnacle Clinical Research, San Antonio, TX, USA
|
| |
|
|
|
|
|
